News
Company Overview: AUTM is the nonprofit leader in efforts to educate, promote and inspire professionals – throughout their careers – to support the development of academic research that changes the world. AUTM’s community is comprised of more than 3,000 members who work in more than 800 universities
NIH is seeking a licensee or collaborator for Nipamovir, an affordable oral treatment for HIV infection with a high barrier to resistance. Nipamovir is a low molecular weight mercaptobenzamide derivative that is simple to produce and can be used to lower or eliminate the infectivity of HIV. It
NIH inventors are seeking a licensee or collaborator for a micro-engineered “thyroid-on-a-chip” that combines human thyroid organoids with integrated micro-vasculature to replicate the gland’s native blood flow and 3-D architecture, enabling rapid, patient-specific drug screening. This technology
Inventors at the NIH National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) are seeking a licensee or collaborator for positive allosteric modulators (PAMs) of the A 3 adenosine receptor (A 3AR), a known therapeutic target. These heterocyclic chemical compounds bind to a lipid